Check out the recent post on Life Science Nation for a review on 2016 Pharma licensing activity and you will find that with increasing competition for assets, they are reaching out to smaller companies earlier, with preclinical assets leading the field.
LSN reports that over 70 pharma firms, located in every corner of the globe, announced a licensing deal last year. Click here for the post.